vs

Side-by-side financial comparison of Apyx Medical Corp (APYX) and Outdoor Holding Co (POWW). Click either name above to swap in a different company.

Apyx Medical Corp is the larger business by last-quarter revenue ($19.2M vs $13.4M, roughly 1.4× Outdoor Holding Co). Outdoor Holding Co runs the higher net margin — 16.7% vs -6.8%, a 23.4% gap on every dollar of revenue. On growth, Apyx Medical Corp posted the faster year-over-year revenue change (34.7% vs -54.1%). Outdoor Holding Co produced more free cash flow last quarter ($5.0M vs $-2.8M).

Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.

Vista Outdoor Inc. was an American designer, manufacturer, and marketer that operated in two segments: shooting sports and outdoor products. It was a "house of brands" with more than 40 labels and subsidiaries.

APYX vs POWW — Head-to-Head

Bigger by revenue
APYX
APYX
1.4× larger
APYX
$19.2M
$13.4M
POWW
Growing faster (revenue YoY)
APYX
APYX
+88.9% gap
APYX
34.7%
-54.1%
POWW
Higher net margin
POWW
POWW
23.4% more per $
POWW
16.7%
-6.8%
APYX
More free cash flow
POWW
POWW
$7.8M more FCF
POWW
$5.0M
$-2.8M
APYX

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
APYX
APYX
POWW
POWW
Revenue
$19.2M
$13.4M
Net Profit
$-1.3M
$2.2M
Gross Margin
62.6%
87.1%
Operating Margin
0.1%
14.7%
Net Margin
-6.8%
16.7%
Revenue YoY
34.7%
-54.1%
Net Profit YoY
71.9%
108.5%
EPS (diluted)
$0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
APYX
APYX
POWW
POWW
Q4 25
$19.2M
$13.4M
Q3 25
$12.9M
$12.0M
Q2 25
$11.4M
$11.9M
Q1 25
$9.4M
$12.6M
Q4 24
$14.2M
$12.5M
Q3 24
$11.5M
$12.0M
Q2 24
$12.1M
$12.3M
Q1 24
$10.2M
$-50.7M
Net Profit
APYX
APYX
POWW
POWW
Q4 25
$-1.3M
$2.2M
Q3 25
$-2.0M
$1.4M
Q2 25
$-3.8M
$-6.5M
Q1 25
$-4.2M
$-77.5M
Q4 24
$-4.6M
$-26.1M
Q3 24
$-4.7M
$-12.4M
Q2 24
$-6.6M
$-14.8M
Q1 24
$-7.6M
$-5.2M
Gross Margin
APYX
APYX
POWW
POWW
Q4 25
62.6%
87.1%
Q3 25
64.4%
87.1%
Q2 25
62.3%
87.2%
Q1 25
60.1%
87.5%
Q4 24
63.0%
87.4%
Q3 24
60.5%
86.9%
Q2 24
61.7%
85.8%
Q1 24
58.1%
Operating Margin
APYX
APYX
POWW
POWW
Q4 25
0.1%
14.7%
Q3 25
-6.5%
5.9%
Q2 25
-22.6%
-50.7%
Q1 25
-32.4%
-213.6%
Q4 24
-21.4%
-163.8%
Q3 24
-31.6%
-50.3%
Q2 24
-45.7%
-50.8%
Q1 24
-64.6%
Net Margin
APYX
APYX
POWW
POWW
Q4 25
-6.8%
16.7%
Q3 25
-15.4%
11.7%
Q2 25
-33.2%
-54.5%
Q1 25
-44.0%
-614.5%
Q4 24
-32.5%
-208.7%
Q3 24
-40.9%
-103.7%
Q2 24
-54.0%
-120.2%
Q1 24
-74.0%
10.3%
EPS (diluted)
APYX
APYX
POWW
POWW
Q4 25
$0.01
Q3 25
$0.01
Q2 25
$-0.06
Q1 25
$-0.67
Q4 24
$-0.23
Q3 24
$-0.11
Q2 24
$-0.19
$-0.13
Q1 24
$-0.22
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
APYX
APYX
POWW
POWW
Cash + ST InvestmentsLiquidity on hand
$31.7M
$69.9M
Total DebtLower is stronger
$37.5M
Stockholders' EquityBook value
$14.5M
$237.3M
Total Assets
$66.8M
$271.7M
Debt / EquityLower = less leverage
2.58×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
APYX
APYX
POWW
POWW
Q4 25
$31.7M
$69.9M
Q3 25
$25.1M
$65.7M
Q2 25
$29.3M
$63.4M
Q1 25
$31.0M
$30.2M
Q4 24
$31.7M
$31.9M
Q3 24
$28.0M
$33.5M
Q2 24
$32.7M
$50.8M
Q1 24
$37.3M
$55.6M
Total Debt
APYX
APYX
POWW
POWW
Q4 25
$37.5M
Q3 25
$37.5M
Q2 25
$37.5M
Q1 25
$37.5M
Q4 24
$37.5M
Q3 24
$37.5M
Q2 24
Q1 24
Stockholders' Equity
APYX
APYX
POWW
POWW
Q4 25
$14.5M
$237.3M
Q3 25
$5.8M
$235.4M
Q2 25
$7.3M
$222.5M
Q1 25
$10.5M
$222.0M
Q4 24
$14.2M
$299.6M
Q3 24
$11.0M
$325.6M
Q2 24
$14.7M
$342.5M
Q1 24
$20.3M
$358.0M
Total Assets
APYX
APYX
POWW
POWW
Q4 25
$66.8M
$271.7M
Q3 25
$57.4M
$270.3M
Q2 25
$58.2M
$269.5M
Q1 25
$60.2M
$297.3M
Q4 24
$64.8M
$355.4M
Q3 24
$60.7M
$368.9M
Q2 24
$65.4M
$398.6M
Q1 24
$70.7M
$403.0M
Debt / Equity
APYX
APYX
POWW
POWW
Q4 25
2.58×
Q3 25
6.41×
Q2 25
5.17×
Q1 25
3.57×
Q4 24
2.64×
Q3 24
3.40×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
APYX
APYX
POWW
POWW
Operating Cash FlowLast quarter
$-2.5M
$5.7M
Free Cash FlowOCF − Capex
$-2.8M
$5.0M
FCF MarginFCF / Revenue
-14.6%
37.6%
Capex IntensityCapex / Revenue
1.4%
4.8%
Cash ConversionOCF / Net Profit
2.55×
TTM Free Cash FlowTrailing 4 quarters
$-9.1M
$-2.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
APYX
APYX
POWW
POWW
Q4 25
$-2.5M
$5.7M
Q3 25
$-3.5M
$3.2M
Q2 25
$-1.2M
$-6.7M
Q1 25
$-702.0K
$-1.5M
Q4 24
$-2.9M
$1.3M
Q3 24
$-4.4M
$-9.3M
Q2 24
$-4.3M
$-547.5K
Q1 24
$-6.3M
$4.3M
Free Cash Flow
APYX
APYX
POWW
POWW
Q4 25
$-2.8M
$5.0M
Q3 25
$-4.1M
$2.5M
Q2 25
$-1.5M
$-7.6M
Q1 25
$-757.0K
$-2.3M
Q4 24
$-3.2M
$720.3K
Q3 24
$-4.6M
$-10.6M
Q2 24
$-4.6M
$-1.3M
Q1 24
$-6.4M
$1.4M
FCF Margin
APYX
APYX
POWW
POWW
Q4 25
-14.6%
37.6%
Q3 25
-31.5%
21.0%
Q2 25
-13.2%
-63.8%
Q1 25
-8.0%
-18.6%
Q4 24
-22.4%
5.8%
Q3 24
-40.0%
-88.3%
Q2 24
-38.0%
-11.0%
Q1 24
-62.2%
-2.8%
Capex Intensity
APYX
APYX
POWW
POWW
Q4 25
1.4%
4.8%
Q3 25
4.0%
5.8%
Q2 25
2.3%
7.5%
Q1 25
0.6%
6.5%
Q4 24
1.7%
4.4%
Q3 24
1.3%
10.4%
Q2 24
2.4%
6.5%
Q1 24
0.3%
-5.7%
Cash Conversion
APYX
APYX
POWW
POWW
Q4 25
2.55×
Q3 25
2.29×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons